GlaxoSmithKline Pharmaceuticals Limited

500660

Equity

ISIN INE159A01016 / Valor 910581

Bombay Stock Exchange Ltd. (Mumbai) (2026-10-06)

INR 2,758.10+0.87%

GlaxoSmithKline Pharmaceuticals Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

GlaxoSmithKline Pharmaceuticals Limited is the Indian affiliate of the multinational GSK group that develops, manufactures and markets prescription medicines and vaccines for the domestic market and select exports. Its business is organized around therapeutic portfolios—commonly including respiratory, anti‑infectives, vaccines and other specialty segments—sold through a field sales force to hospitals, physicians, retail pharmacies and institutional buyers, as well as via government tenders and partner/licensing arrangements. The company combines local manufacturing and regulatory activity with access to research and product assets from the broader GSK network, and its financial performance is driven by product sales, new launches, pricing and reimbursement policies, patent and competition dynamics, and strategic collaborations.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

0.82%1Y

77.9%3Y

85.3%5Y

Performance

25.1%1Y

34.3%3Y

29.6%5Y

Volatility